Chemogenetic recruitment of specific interneurons suppresses seizure activity

Current anti-epileptic medications that boost synaptic inhibition are effective in reducing several types of epileptic seizure activity. Nevertheless, these drugs can generate significant side-effects and even paradoxical responses due to the broad nature of their action. Recently developed chemogen...

ver descrição completa

Detalhes bibliográficos
Main Authors: Calin, A, Stancu, M, Zagrean, A, Jefferys, J, Ilie, A, Akerman, C
Formato: Journal article
Publicado em: Frontiers Media 2018
_version_ 1826299509449162752
author Calin, A
Stancu, M
Zagrean, A
Jefferys, J
Ilie, A
Akerman, C
author_facet Calin, A
Stancu, M
Zagrean, A
Jefferys, J
Ilie, A
Akerman, C
author_sort Calin, A
collection OXFORD
description Current anti-epileptic medications that boost synaptic inhibition are effective in reducing several types of epileptic seizure activity. Nevertheless, these drugs can generate significant side-effects and even paradoxical responses due to the broad nature of their action. Recently developed chemogenetic techniques provide the opportunity to pharmacologically recruit endogenous inhibitory mechanisms in a selective and circuit-specific manner. Here we use chemogenetics to assess the potential of supressing epileptiform activity by enhancing the synaptic output from three major interneuron populations in the rodent hippocampus: parvalbumin (PV), somatostatin (SST) and vasoactive intestinal peptide (VIP) expressing interneurons. To target different neuronal populations, promoter-specific cre-recombinase mice were combined with viral-mediated delivery of chemogenetic constructs. Targeted electrophysiological recordings were then conducted in an in vitro model of chronic, drug-resistant epilepsy. In addition, behavioural video-scoring was performed in an in vivo model of acutely triggered seizure activity. Pre-synaptic and post-synaptic whole cell recordings in brain slices revealed that each of the three interneuron types increase their firing rate and synaptic output following chemogenetic activation. However, the interneuron populations exhibited different effects on epileptiform discharges. Recruiting VIP interneurons did not change the total duration of epileptiform discharges. In contrast, recruiting SST or PV interneurons produced robust suppression of epileptiform synchronisation. PV interneurons exhibited the strongest effect per cell, eliciting at least a five-fold greater reduction in epileptiform activity than the other cell types. Consistent with this, we found that in vivo chemogenetic recruitment of PV interneurons suppressed convulsive behaviours by more than 80%. Our findings support the idea that selective chemogenetic enhancement of inhibitory synaptic pathways offers potential as an anti-seizure strategy.
first_indexed 2024-03-07T05:03:01Z
format Journal article
id oxford-uuid:d8f6b7e8-c63b-4d0b-9b9b-eb9507a3fabd
institution University of Oxford
last_indexed 2024-03-07T05:03:01Z
publishDate 2018
publisher Frontiers Media
record_format dspace
spelling oxford-uuid:d8f6b7e8-c63b-4d0b-9b9b-eb9507a3fabd2022-03-27T08:52:30ZChemogenetic recruitment of specific interneurons suppresses seizure activityJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d8f6b7e8-c63b-4d0b-9b9b-eb9507a3fabdSymplectic Elements at OxfordFrontiers Media2018Calin, AStancu, MZagrean, AJefferys, JIlie, AAkerman, CCurrent anti-epileptic medications that boost synaptic inhibition are effective in reducing several types of epileptic seizure activity. Nevertheless, these drugs can generate significant side-effects and even paradoxical responses due to the broad nature of their action. Recently developed chemogenetic techniques provide the opportunity to pharmacologically recruit endogenous inhibitory mechanisms in a selective and circuit-specific manner. Here we use chemogenetics to assess the potential of supressing epileptiform activity by enhancing the synaptic output from three major interneuron populations in the rodent hippocampus: parvalbumin (PV), somatostatin (SST) and vasoactive intestinal peptide (VIP) expressing interneurons. To target different neuronal populations, promoter-specific cre-recombinase mice were combined with viral-mediated delivery of chemogenetic constructs. Targeted electrophysiological recordings were then conducted in an in vitro model of chronic, drug-resistant epilepsy. In addition, behavioural video-scoring was performed in an in vivo model of acutely triggered seizure activity. Pre-synaptic and post-synaptic whole cell recordings in brain slices revealed that each of the three interneuron types increase their firing rate and synaptic output following chemogenetic activation. However, the interneuron populations exhibited different effects on epileptiform discharges. Recruiting VIP interneurons did not change the total duration of epileptiform discharges. In contrast, recruiting SST or PV interneurons produced robust suppression of epileptiform synchronisation. PV interneurons exhibited the strongest effect per cell, eliciting at least a five-fold greater reduction in epileptiform activity than the other cell types. Consistent with this, we found that in vivo chemogenetic recruitment of PV interneurons suppressed convulsive behaviours by more than 80%. Our findings support the idea that selective chemogenetic enhancement of inhibitory synaptic pathways offers potential as an anti-seizure strategy.
spellingShingle Calin, A
Stancu, M
Zagrean, A
Jefferys, J
Ilie, A
Akerman, C
Chemogenetic recruitment of specific interneurons suppresses seizure activity
title Chemogenetic recruitment of specific interneurons suppresses seizure activity
title_full Chemogenetic recruitment of specific interneurons suppresses seizure activity
title_fullStr Chemogenetic recruitment of specific interneurons suppresses seizure activity
title_full_unstemmed Chemogenetic recruitment of specific interneurons suppresses seizure activity
title_short Chemogenetic recruitment of specific interneurons suppresses seizure activity
title_sort chemogenetic recruitment of specific interneurons suppresses seizure activity
work_keys_str_mv AT calina chemogeneticrecruitmentofspecificinterneuronssuppressesseizureactivity
AT stancum chemogeneticrecruitmentofspecificinterneuronssuppressesseizureactivity
AT zagreana chemogeneticrecruitmentofspecificinterneuronssuppressesseizureactivity
AT jefferysj chemogeneticrecruitmentofspecificinterneuronssuppressesseizureactivity
AT iliea chemogeneticrecruitmentofspecificinterneuronssuppressesseizureactivity
AT akermanc chemogeneticrecruitmentofspecificinterneuronssuppressesseizureactivity